Ginkgo Pharma Co., Ltd.   Report issue

For profit Phase 3
Founded: Suzhou China (2009)

Organization Overview

First Clinical Trial
2018
NCT04001608
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Ginkgopharma CO., LTD | Ginkgo Pharma Co., Ltd.